‘Sec. 1. 16 MRSA §357, last ¶, as amended by PL 2009, c. 447, §17, is further amended to read:
Notwithstanding this section, the result of a laboratory or any other test kept by a hospital or other medical facility that reflects an alcohol level, a detectable urine-drug level and , a detectable blood-drug level or a drug concentration of either blood or urine may not be excluded as evidence in a criminal or civil proceeding by reason of any claim of confidentiality or privilege and may be admitted as long as the result is relevant and reliable evidence if the proceeding is one in which the operator of a motor vehicle, snowmobile, all-terrain vehicle or watercraft is alleged to have operated under the influence of intoxicating liquor or drugs and the court is satisfied that probable cause exists to believe that the operator committed the offense charged.
Sec. 2. 29-A MRSA §2401, sub-§8, as amended by PL 2009, c. 447, §34, is further amended to read:
Sec. 3. 29-A MRSA §2431, sub-§1, as amended by PL 2009, c. 447, §44, is further amended to read:
Sec. 4. 29-A MRSA §2432, as amended by PL 2009, c. 447, §48, is further amended to read:
§ 2432. Alcohol level; confirmed positive drug or metabolite test results; evidentiary weight
Sec. 5. 29-A MRSA §2453-A is enacted to read:
§ 2453-A. Suspension on administrative determination; operating under the influence of drugs
Section 2481, subsections 2 and 3 apply to the report submitted by the drug recognition expert.
Sec. 6. 29-A MRSA §2472, sub-§3, as amended by PL 2009, c. 447, §58, is further amended to read:
Sec. 7. 29-A MRSA §2472, sub-§4, as amended by PL 2009, c. 447, §60, is further amended to read:
If the Secretary of State determines that the person operated the motor vehicle at the time of the offense with a passenger under 21 years of age, an additional suspension period of 180 days must be imposed.
Sec. 8. 29-A MRSA §2472, sub-§5, as amended by PL 2009, c. 447, §§61 and 62, is further amended to read:
Sec. 9. 29-A MRSA §2482, sub-§2, ¶C, as amended by PL 2003, c. 434, §34 and affected by §37, is further amended to read:
Sec. 10. 29-A MRSA §2482, sub-§2, ¶F, as amended by PL 2009, c. 447, §64, is further amended to read:
Sec. 11. 29-A MRSA §2502, sub-§1, as amended by PL 2001, c. 511, §7, is further amended to read:
Sec. 12. 29-A MRSA §2503, sub-§1, as amended by PL 1997, c. 737, §21, is further amended to read:
(1) Between the residence and a place of employment or in the scope of employment, or both; or
(2) Between the residence and an educational facility attended by the petitioner if the suspension is under section 2472, subsection 3, paragraph B or C for a first offense;
Sec. 13. 29-A MRSA §2508, sub-§1, as amended by PL 2009, c. 482, §1, is further amended to read:
Sec. 14. 29-A MRSA §2525, sub-§§1 and 2, as enacted by PL 1993, c. 683, Pt. A, §2 and affected by Pt. B, §5, are further amended to read:
Sec. 15. 29-A MRSA §2526, as enacted by PL 1993, c. 683, Pt. A, §2 and affected by Pt. B, §5, is amended to read:
§ 2526. Drug recognition experts
(1) Law enforcement officers who have demonstrated proficiency and experience in standardized field sobriety testing and the ability to complete the training and function as drug recognition technicians experts; and
(2) Employed by law enforcement agencies that have the facilities, equipment and other resources necessary for the effective functioning of drug recognition technicians experts.